Chaoliang Ge

Chaoliang Ge


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MJMeijie Jiang
Meijie Jiang
CHChunmei Huang
Chunmei Huang
QWQiong Wu
Qiong Wu
YSYong Su
Yong Su
XWXinming Wang
Xinming Wang
CGChaoliang Ge
Chaoliang Ge

27 October 2022 in Cancers
Verified
Journal Article
Open access
PDF file
WXwang xinming
wang xinming
CYChunlan Yang
Chunlan Yang
Heinrich KornerHeinrich Korner
Heinrich Korner
CGChaoliang Ge
Chaoliang Ge
Tumor Necrosis Factor was one of the first cytokines described in the literature as a soluble mediator of cytotoxicity to tumors. Over the years, more extensive research that tried to employ Tumor Necrosis Factor in cancer treatments showed nevertheless that it mainly functioned as a proinflammatory cytokine. However, this did not stop the search for the holy grail of cancer research: A cytokine that could act as a one-stop treatment for solid tumors and lymphomas. This review will summarize the long experimental history of Tumor Necrosis Factor that caused the initial observations of a tumor necrotizing cytokine that could serve as a potential cancer treatment and discuss the current state of research into this side of the activities of Tumor Necrosis Factor.

24 November 2015 in Chinese Journal of Natural Medicines
Verified
Journal Article
Closed access
CGChaoliang Ge
Chaoliang Ge
XWXin-Ming Wang
Xin-Ming Wang
ZHZhao-Gang Huang
Zhao-Gang Huang
QXQuan Xia
Quan Xia
NWNing Wang
Ning Wang
DXDu-Juan Xu
Du-Juan Xu

26 August 2020 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
JHJialing Han
Jialing Han
LCLonghao Cheng
Longhao Cheng
YZYa Zhu
Ya Zhu
Xiaowei XuXiaowei Xu
Xiaowei Xu
CGChaoliang Ge
Chaoliang Ge
Human NAD(P)H: quinone oxidoreductase (hNQO1) is an important biomarker for human malignant tumors. Detection of NQO1 accurately is of great significance to improve the early diagnosis of cancer and prognosis of cancer patients. In this study, based on the covalent assembly strategy, hNQO1-activated fluorescent probes 1 and 2 are constructed by introducing coumarin precursor 2-cyano-3-(4-(diethylamino)-2-hydroxyphenyl) acrylic acid and self-immolative linkers. Under reaction with hNQO1 and NADH, turn-on fluorescence appears due to in-situ formation of the organic fluorescent compound 7-diethylamino-3-cyanocoumarin, and fluorescent intensity changes significantly. Probe 1 and 2 for detection of hNQO1 are not interfered by other substances and have low toxicity in cells. In addition to quantitative detection of hNQO1 in vitro, they have also been successfully applied to fluorescent imaging in living cells.

11 November 2025 in Chinese Medicine
Verified
Journal Article
Open access
PDF file
FZFangsi Zhu
Fangsi Zhu
YDYijie Ding
Yijie Ding
LCLuyun Chen
Luyun Chen
RFRou Fang
Rou Fang
CHChengfeng Huang
Chengfeng Huang
CGChaoliang Ge
Chaoliang Ge
Background: Sini-San (SNS), a classical traditional Chinese medicinal formula, has demonstrated promising potential in mitigating the progression of liver fibrosis (LF). Increasing evidence highlights that disruption of bile acids (BAs) homeostasis is critically involved in the pathogenesis and progression of LF, suggesting that targeting BAs metabolism could represent a therapeutic strategy. This study aimed to explore whether the protective effects of SNS against LF are mediated through modulation of BAs metabolism and associated regulatory pathways. Methods: The chemical constituents of SNS were characterized using high-performance liquid chromatography (HPLC). LF models were established in mice through intraperitoneal injection of carbon tetrachloride (CCl 4 ) or feeding a high-fat, high-sugar (HFHS) diet. SNS was administered orally. Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and hydroxyproline (HYP) levels were measured, and liver histopathology was evaluated by hematoxylin–eosin (HE), Masson and TUNEL staining. The expression of fibrosis- and apoptosis-associated markers (Collagen-1, α-SMA, Bcl-2, Bax, and Caspase-3) was assessed by RT-qPCR and Western blotting. Serum BAs profiles were analyzed using LC–MS/MS, and molecules involved in BA metabolism (Fxr, Cyp7a1, Cyp27a1, Bsep, Ntcp, Asbt and OATP) were examined. Gut microbiota composition was analyzed through 16S rRNA gene sequencing. To investigate the mechanisms by which SNS regulates BAs homeostasis, additional experiments were conducted under choline chelation, pseudo-sterile conditions, and in fxr −/− mice. Results: In LF mice induced by CCl 4 or HFHS diet, significant alterations were observed in BAs levels and composition. The expression of BAs-synthesizing enzymes (CYP7A1, CYP27A1), BAs transporters ( Bsep, Ntcp, Asbt and Oatp ), and the feedback regulatory receptor FXR was markedly dysregulated. Meanwhile, gut microbiota abundance and composition were also significantly disrupted, indicating a disturbance of BAs homeostasis. SNS treatment effectively alleviated liver injury and fibrosis, corrected BAs imbalance, regulated the expression of BAs-related genes, and restored microbial diversity. However, the antifibrotic effects of SNS were reversed by choline chelation, antibiotic treatment, and fxr knockout. Conclusions: SNS may exert anti-hepatic fibrosis effects by modulating BAs metabolism and gut-liver axis pathways, ultimately restoring BAs homeostasis. These findings provide new insights into the therapeutic mechanisms of SNS and suggest its potential as a multitargeted strategy for LF treatment.

23 January 2024 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
CZCheng Zhang
Cheng Zhang
FZFangsi Zhu
Fangsi Zhu
YCYuhong Chen
Yuhong Chen
LHLiang He
Liang He
TZTengyue Zhang
Tengyue Zhang
BWBAOMING WU
BAOMING WU